Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
Spoorendonk, J. A., Briere, J.-B., Bowrin, K., Millier, A., Coppens, M., Tempelaar, S., Verheggen, B.
Published in Journal of medical economics (01.01.2021)
Published in Journal of medical economics (01.01.2021)
Get full text
Journal Article
THE COST-EFFECTIVENESS OF AN EXTENDED COURSE (12+12 WEEKS) OF VARENICLINE PLUS BRIEF COUNSELLING COMPARED WITH OTHER REIMBURSED SMOKING CESSATION INTERVENTIONS IN BELGIUM, FROM A PUBLIC PAYER PERSPECTIVE
Knight, C, Marbaix, S, Annemans, L, Prignot, J, Bowrin, K
Published in Acta clinica belgica (English ed. Online) (01.11.2012)
Published in Acta clinica belgica (English ed. Online) (01.11.2012)
Get full text
Journal Article
PCV29 COST-EFFECTIVENESS OF CORONARY AND PERIPHERAL ARTERY DISEASE TREATMENTS
Soini, E., Virtanen, O., Briere, J.B., Bowrin, K., Millier, A.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PNS322 REVIEW OF METHODOLOGICAL APPROACHES TO ANALYSE LONGITUDINAL UTILITY DATA
Majewska, R., Jabłońska, K., Młynarczyk, D., Briere, J.B., Bowrin, K., Millier, A.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
Kalogeropoulou, M., Gkouvitsos, I., Barlogiannis, T., Bowrin, K., Briere, J.B., Millier, A., Karabis, A.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
Kalogeropoulou, M., Gkouvitsos, I., Barlogiannis, T., Bowrin, K., Briere, J.B., Millier, A., Karabis, A.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCV20 - NUMBER NEEDED TO TREAT FOR ORAL ANTI-COAGULANTS VERSUS VKA IN STROKE PREVENTION IN ATRIAL FIBRILLATION
Briere, J., Bowrin, K., Millier, A., Toumi, M., Wojciechowski, P., Taieb, V.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK
Cowie, M.R., Lamy, A., Levy, P., Mealing, S., Millier, A., Mernagh, P., Cristeau, O., Briere, J.B., Bowrin, K.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCV39 Cost-Effectiveness of Rivaroxaban in the Treatment of Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease in Spain
Gonzalez-Juanatey, J.R., Gómez, J.J., Lozano, F.S., Valle, A., Bowrin, K., Briere, J.B., Llorac, A., Millier, A., de Miguel, C., Diana, N.
Published in Value in health (01.12.2020)
Published in Value in health (01.12.2020)
Get full text
Journal Article
POSA45 Impact of Nonadherence to DOACs Among Patients with Non-Valvular Atrial Fibrillation in Sweden: Results from a Real-World Cost-Utility Analysis
Blomström Lundqvist, C, Själander, S, Garcia Rodriguez, LA, Åkerborg, Ö, Jin, G, Caleyachetty, A, Huelsebeck, M, Bowrin, K, Schaefer, B, Mahdessian, H, Hofmeister, L, Levin, LÅ
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch: The Repair Study Cross-Sectional Results
Briere, J, Crovato, E, Bowrin, K, Costanzo, M, Pagliula, F, Perrone, V, Sangiorgi, D, Buda, S, Degli Esposti, L
Published in Value in health (01.11.2016)
Published in Value in health (01.11.2016)
Get full text
Journal Article
PCV130 - Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch: The Repair Study Cross-Sectional Results
Briere, J, Crovato, E, Bowrin, K, Costanzo, M, Pagliula, F, Perrone, V, Sangiorgi, D, Buda, S, Degli Esposti, L
Published in Value in health (01.11.2016)
Published in Value in health (01.11.2016)
Get full text
Journal Article
PCV157 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG BID WITH ASA VERSUS ASA MONOTHERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SLOVAKIA
Psota, M., Psenkova, M., Briere, J.B., Bowrin, K., Millier, A., Paulis, L., Krockova, R.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article